5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers

SIMPLE SUMMARY: 5-aminolevulinic acid (5-ALA) is administered orally before brain tumor surgery to improve intraoperative visualization of tumor tissue. In comparison to most of the aggressive high-grade gliomas, only a few low-grade gliomas (LGG) demonstrate visible fluorescence during surgery. As...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosmann, Arthur, Millesi, Matthias, Wadiura, Lisa I., Kiesel, Barbara, Mercea, Petra A., Mischkulnig, Mario, Borkovec, Martin, Furtner, Julia, Roetzer, Thomas, Wolfsberger, Stefan, Phillips, Joanna J., Berghoff, Anna S., Hervey-Jumper, Shawn, Berger, Mitchel S., Widhalm, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196836/
https://www.ncbi.nlm.nih.gov/pubmed/34064222
http://dx.doi.org/10.3390/cancers13112540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196836/
https://www.ncbi.nlm.nih.gov/pubmed/34064222
http://dx.doi.org/10.3390/cancers13112540

Ejemplares similares